SVP, Global Commercial Development
Jim has led several disruptive medical-device, med-tech, and digital healthcare companies through all phases of development and scale. Mr. Breidenstein joined Pear Therapeutics as the Global Commercial Lead where he led the first and only prescription digital therapeutic for the field of addiction. Jim spent many years at Kyphon, a first-in-class spinal surgical company, where he held VP/GM leadership positions that contributed to their ultimate acquisition. Jim also led the commercial efforts at Neuronetics, resulting in a subsequent IPO. In addition, Mr. Breidenstein has held senior leadership positions such as, President, Chief Operating Officer, Chief Commercial Officer and Senior VP in both publicly traded and venture capital backed organizations.